Market Place
Sourcing Support
Lupin Launches Dapagliflozin Tablets In The United States
10 Apr 2026 //
PR NEWSWIRE
Lupin Foundation Expands NCD Care Access In Rajasthan
10 Apr 2026 //
INDPHARMAPOST
Lupin Gets ANDA Approval For Dapagliflozin, Metformin Er Tablets
09 Apr 2026 //
EXPRESSPHARMA
Lupin Gets FDA Approval For Dapagliflozin Tablets In US
07 Apr 2026 //
PR NEWSWIRE
Lupin Earns Global Great Place To Work Certification
07 Apr 2026 //
EXPRESSPHARMA
Lupin’s Generics Dapagliflozin & Metformin Receives Nod in US
06 Apr 2026 //
FDA
Lupin’s Generics Dapagliflozin Receives Approval in US
06 Apr 2026 //
FDA
Lupin Completes Acquisition Of Visufarma
04 Apr 2026 //
PHARMIWEB
Lupin Gets Tentative FDA Nod For Sugammadex Injection
31 Mar 2026 //
PR NEWSWIRE
Lupin’s Generics Sugammadex Receives Tentative Approval in US
26 Mar 2026 //
FDA
Lupin Gets Tentative FDA Approval for Pitolisant Tablets
25 Mar 2026 //
PR NEWSWIRE
Lupin’s Generics Pitolisant Receives Tentative Approval in US
23 Mar 2026 //
FDA
Lupin Pharma`s Manufacturing Arm Expands Dabhasa Facility
20 Mar 2026 //
PRESS RELEASE
Zydus, Lupin Partner to Co-Market Semaglutide in India
17 Mar 2026 //
ECONOMICTIMES
Lupin Leads Global Pharma In S&P ESG Rankings
28 Feb 2026 //
INDPHARMAPOST
Lupin Gets US FDA EIR For Goa Facility With VAI Status
27 Feb 2026 //
PRESS RELEASE
Lupin CEO, Vinita Gupta Honored On 2026 CNBC Changemakers List
27 Feb 2026 //
PR NEWSWIRE
Lupin Launches Brivaracetam Oral Solution In US
25 Feb 2026 //
PRESS RELEASE
Lupin’s Generics Brivaracetam Receives Approval in US
23 Feb 2026 //
FDA
Lupin Secures EC Approval for Ranluspec, Ranibizumab Biosimilar
23 Feb 2026 //
PRESS RELEASE
Lupin Signs Supply Deal To Launch Antidepressant In Canada
16 Feb 2026 //
PRESS RELEASE
Lupin Q3 FY26 Consolidated PAT Jumped 37.4% To Rs. 1,180.5 Cr
14 Feb 2026 //
PRESS RELEASE
Pharma Inc Urges Streamlined Regulatory Process For Growth Pill
09 Feb 2026 //
BUSINESS STD
Sun Pharma, Dr. Reddy`s, Lupin Advocate Major Drug Innovation
09 Feb 2026 //
ECONOMICTIMES
Lupin Founder`s Book `Made In India` Launched In Mumbai
09 Feb 2026 //
PRESS RELEASE
Lupin Introduces Topiramate Extended-Release Capsules In US
05 Feb 2026 //
PRESS RELEASE
Lupin Launches Dasatinib Tablets In The United States
02 Feb 2026 //
PRESS RELEASE
Lupin, TB Alliance Partner To Advance Telacebec For TB Treatment
02 Feb 2026 //
PRESS RELEASE
Lupin Earns Top ESG Rating For Climate And Water Security
23 Jan 2026 //
PRESS RELEASE
Lupin, Galenicum Sign Semaglutide Deal In 23 Countries
22 Jan 2026 //
PRESS RELEASE
Lupin and Gan & Lee Pharma Enter Exclusive Licensing Deal
29 Dec 2025 //
INDPHARMAPOST
Lupin Signs Licensing Deal With Neopharmed For Plasil
18 Dec 2025 //
PRESS RELEASE
Lupin Receives EIR from US FDA for its Nagpur Injectable Facility
18 Dec 2025 //
PRESS RELEASE
Lupin Receives Positive CHMP Opinion For Biosimilar Ranibizumab
18 Dec 2025 //
PRESS RELEASE
Lupin Secures Sbti Validation For Emission Reduction Targets
17 Dec 2025 //
INDPHARMAPOST
Lupin Manufacturing Solutions partners with PolyPeptide
12 Dec 2025 //
PRESS RELEASE
Lupin Inks Exclusive U.S. Licensing Deal For Armlupeg
06 Dec 2025 //
PRESS RELEASE
Lupin Receives Tentative U.S. FDA Approval For Siponimod Tablets
05 Dec 2025 //
PRESS RELEASE
Lupin Receives FDA Approval For Biosimilar Armlupeg
01 Dec 2025 //
INDPHARMAPOST
Lupin, TPG, EQT Eye Lalvani Family-Owned Vitabiotics
01 Dec 2025 //
ECONOMICTIMES
Lupin Foundation Achieves CRISIL`s Highest VO 1A Rating
29 Nov 2025 //
INDPHARMAPOST
Neuland, Lupin, Divi`s Lead CDMO Surge Amid U.S. Generics Woes
25 Nov 2025 //
BUSINESS STD
FDA Inspects Lupin`s Nagpur Unit-1, Finds No Issues
15 Nov 2025 //
PRESS RELEASE
Lupin Launches Long-Acting Risperidone In US
15 Nov 2025 //
PRESS RELEASE
Lupin Achieves S&P Global ESG Score Of 91
14 Nov 2025 //
INDPHARMAPOST
Lupin Surpasses Pharma Industry Average With S&P Global ESG
13 Nov 2025 //
EXPRESSPHARMA
Lupin Receives EIR From FDA For Its Aurangabad Facility
13 Nov 2025 //
PRESS RELEASE
Lupin Q2 PAT Rises 73% on Strong Growth Across Key Global Markets
06 Nov 2025 //
BUSINESS STD
Lupin Receives EIR From US FDA For Its Pithampur Unit-3 Facility
06 Nov 2025 //
PRESS RELEASE
Lupin Digital Health Introduces AI Cardiometabolic Platform
30 Oct 2025 //
EXPRESSPHARMA
Lupin Inaugurates New Headquarters In Bridgewater, NJ
28 Oct 2025 //
PRESS RELEASE
Lupin Launches Authorized Generic Of Ravicti In US
24 Oct 2025 //
INDPHARMAPOST
Lupin Presents Phase 1 Data On LNP3693 At ESMO Congress 2025
13 Oct 2025 //
PR NEWSWIRE
Lupin To Lay Out $250M For New Fla. Manufacturing Facility
10 Oct 2025 //
PRESS RELEASE
Lupin Launches Partnership to Expand Long-Acting Injectables
09 Oct 2025 //
PR NEWSWIRE
Lupin To Build $250 Million Manufacturing Facility In Florida
08 Oct 2025 //
INDPHARMAPOST
Gilead Inks Biktarvy Settlements With 3 Generic Drug Makers
07 Oct 2025 //
FIERCE PHARMA
Lupin Launches Liraglutide Injection In US
04 Oct 2025 //
INDPHARMAPOST
Lupin Gets FDA Nod For Rivaroxaban Oral Suspension
30 Sep 2025 //
EXPRESSPHARMA
Lupin Acquires Visufarma To Enhance Ophthalmology Portfolio
30 Sep 2025 //
PRESS RELEASE
